Related Experiment Video
Updated: Jul 9, 2025
07:15
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
442
Experimental models for elderly patients with membranous nephropathy: Application and advancements
Xinyue Tang1, Haoran Dai2, Yuehong Hu1
1Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, 23 Meishuguanhou Street, Dongcheng District, Beijing 100010, China.
Experimental Gerontology
|December 2, 2023
Summary
New animal and podocyte models for membranous nephropathy (MN) are crucial for understanding this autoimmune kidney disease. These models, focusing on specific antigens like PLA2R1, offer better insights into pathogenesis and targeted therapies for elderly patients.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Membranous nephropathy (MN) is a leading cause of nephrotic syndrome in the elderly.
- It is an autoimmune glomerular disorder involving immune complex deposition.
- Existing rodent models have limitations due to species-specific target antigens.
Purpose of the Study:
- To review recent antigen-specific animal models for MN.
- To discuss advancements in in vitro podocyte models for MN research.
- To provide insights into future experimental model development for MN.
Main Methods:
- Compilation of recent literature on antigen-specific MN animal models (e.g., PLA2R1, THSD7A).
- Review of novel in vitro podocyte models relevant to MN.
- Analysis of immune responses and pathological characteristics in these models.
Main Results:
- Development of antigen-specific MN models offers improved platforms for in vivo research.
- Advancements in podocyte models facilitate in vitro studies of MN.
- These models elucidate immune responses and pathological features of MN.
Conclusions:
- Recent antigen-specific animal and podocyte models represent significant progress in MN research.
- These models are vital for understanding MN pathogenesis.
- They are essential for developing targeted therapies to improve outcomes for elderly MN patients.
